193 related articles for article (PubMed ID: 26356615)
1. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].
Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615
[TBL] [Abstract][Full Text] [Related]
2. [Modern methods of energy homeostasis correction in elderly patients].
Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN
Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of antioxidant energocorreсtion in brain infarction (results of a multicenter randomized trial)].
Rumyantseva SA; Silina EV; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Kovalenko AL; Kabaeva EN; Stupin VA
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):49-55. PubMed ID: 25591516
[TBL] [Abstract][Full Text] [Related]
4. [Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction].
Chichanovskaia LV; Tsukurova LA; Kovalenko AL; Nazarov MV; Lukin DI; Rumiantseva SA; Silina EV; Stupin VA; Nedorostkova TIu; Kabaeva EN; Eliseev EV
Eksp Klin Farmakol; 2015; 78(1):21-6. PubMed ID: 25826870
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593
[TBL] [Abstract][Full Text] [Related]
6. [Effect of early correction of energy and free-radical homeostasis on the clinical-morphological presentation of cerebral infarction].
Rumiantseva SA; Fedin AI; Bolevich SB; Silina EV; Vasil'ev IuD; Men'shova NI; Iliukhina OA; Goluzova IuN
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):16-21. PubMed ID: 20823824
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of cytoflavin in the treatment of burns patients with toxic and post-hypoxic encephalopathy].
Pochepen' ON
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):23-9. PubMed ID: 21183910
[TBL] [Abstract][Full Text] [Related]
8. [Antioxidant therapy in discirculatory encephalopathy].
Antipenko EA; Gustov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819
[No Abstract] [Full Text] [Related]
9. [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
Bogomolov MS; Sedov VM; Edovina LN; Luk'ianov IuV; Slobodianiuk VV
Vestn Khir Im I I Grek; 2011; 170(1):43-6. PubMed ID: 21506354
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of cytoflavin in the combined treatment of patients during acute phase of ischemic stroke].
Shestakov VV; Kosenkova NV; Kichigina EV; Larikova TN; Starikova NL
Klin Med (Mosk); 2011; 89(1):38-40. PubMed ID: 21516764
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy of cytoflavin in the treatment of burnout syndrome].
Chutko LS; Surushkina SY; Yakovenko EA; Rozhkova AV; Anisimova TI; Bondarchuk YL
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):66-70. PubMed ID: 26525625
[TBL] [Abstract][Full Text] [Related]
12. [Study cytoflavin dose-dependent effect in the treatment of acute ischemic stroke].
Sazonov IE; Kudinov AA; Fedotova EP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):64-67. PubMed ID: 28374695
[TBL] [Abstract][Full Text] [Related]
13. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].
Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency].
Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033
[TBL] [Abstract][Full Text] [Related]
15. [Experience of cytoflavin administration for treating acute carbon monoxide poisoning].
Zobnin IuV; Petrova AG; Provado IP; Afanas'ev VV
Eksp Klin Farmakol; 2011; 74(10):39-42. PubMed ID: 22238986
[TBL] [Abstract][Full Text] [Related]
16. [Possibilities of treatment of multiple sclerosis exacerbations without corticosteroids: a role of metabolic and antioxidant therapy].
Bisaga GN; Odinak MM; Boĭko AN; Mel'nik IuB; Popova NF
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2):44-8. PubMed ID: 21350423
[TBL] [Abstract][Full Text] [Related]
17. [Positive effect of cytoflavin on metabolic status changes in patients with burn disorder].
Polutova NV; Ostrovskiĭ NV; Romantsov MG; Chesnokova NP
Eksp Klin Farmakol; 2011; 74(7):33-7. PubMed ID: 21894767
[TBL] [Abstract][Full Text] [Related]
18. [Efficiency of intensive care with cytoflavin in patients of advanced age in combined traumatic brain injury].
Lebedeva EA; Belousova ME; Kurtasov AA; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
Adv Gerontol; 2014; 27(3):578-83. PubMed ID: 25827011
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of cytoflavin in patients in the acute ischemic stroke].
Odinak MM; Skvortsova VI; Vozniuk IA; Rumiantseva SA; Stakhovskaia LV; Klocheva EG; Novikova LB; Ianishevskiĭ SN; Golokhvastov SIu; Tsygan NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):29-36. PubMed ID: 21311484
[TBL] [Abstract][Full Text] [Related]
20. [Perspectives of treatment of patients with ischemic stroke: the place and the role of cytoflavin].
Trofimova SA; Balunov OA; Dubinina EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):49-53. PubMed ID: 20559274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
